Jennifer Feighner, MD
Hospitalist · Tulsa, OKNPI 1639191265
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Johnson & Johnson at 47.2% of the total. Reporting peaked in 2021 at $257 and has fallen 93.1% since, to $18 in 2025.
Across 9 payments — averaging $40.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$173
- Edwards Lifesciences$122
- AstraZeneca$23
- Novartis$18
- Boston Scientific$18
- Vapotherm Inc$12
What the payments were for
- Food & beverage$365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $173 |
| Edwards Lifesciences | 1 | $122 |
| AstraZeneca | 1 | $23 |
| Novartis | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Vapotherm Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$365 in reported general payments places this provider in the 80th percentile of 234 hospitalist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $9,787 |
| CefuroximeCefuroxime Axetil | 42 | $507 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $463 |
| Metoprolol Succinate | 28 | $281 |
| Doxycycline Hyclate | 20 | $191 |
| Potassium Chloride | 15 | $174 |
| Amlodipine Besylate | 16 | $164 |
| Azithromycin | 34 | $160 |
| Ondansetron Hcl | 24 | $148 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $146 |
| Prednisone | 45 | $133 |
| Atorvastatin Calcium | 13 | $129 |
| Amiodarone Hcl | 14 | $90 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $70 |
| ClopidogrelClopidogrel Bisulfate | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Tulsa
- Kishen PatelTulsa$4K
- Mark ThngTulsa$4K
- Jawad BabarTulsa$2K
- Bhavik PatelTulsa$2K
- Nishant PaudelTulsa$1K
- Ziad SousTulsa$1K
- Caleb SevernsTulsa$1K
- Dustin FravelTulsa$980
- Kendra WilsonTulsa$950
- Sudha NiraulaTulsa$936
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.